As of June 2026, 1 paid clinical trial is recruiting for Lung disease in Methuen, Massachusetts. Lung disease trials cover asthma biologics, COPD inhalers, antifibrotic therapies, CFTR modulators, and new lung cancer treatments across the full spectrum of chronic and acute respiratory illness. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Methuen has approximately 23 recruiting research studies across a wide range of therapeutic areas. Massachusetts is a global epicenter of biomedical research, anchored by Harvard-affiliated hospitals (MGH, Brigham and Women's, Dana-Farber), Boston Children's Hospital, and the Kendall Square biotech corridor in Cambridge.
Researchers run research studies in Methuen, MA at 12 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dana Farber-Merrimack Valley | Stage IIIB Lung Cancer AJCC v8, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma | 7 |
| ActivMed Practices and Research | Alzheimer's Disease, Chronic Low-back Pain, Diabetic Neuropathic Pain | 2 |
| Activmed Practices & Research, Llc - Methuen | Depression, Major Depressive Disorder, Major Depressive Disorder (MDD) | 2 |
| Dana-Farber Cancer Instiute - Merrimack Valley | Breast Cancer, Gastrointestinal Cancer, HER2-positive Breast Cancer | 2 |
| ActivMed Practices & Research | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| ActivMed Practices & Research, Inc. | Cognitive Function, Contrast Media, Motor Function | 1 |
| Dana Farber Cancer Institute - Merrimack Valley | Breast Cancer | 1 |
| Dana Farber Cancer Institute at Merrimack Valley | B-cell Malignancy, Low-grade, Hematological Malignancies, IgG Monoclonal Gammopathy of Uncertain Significance | 1 |
| Dana-Farber Cancer Institude at Merrimack Valley | Triple Negative Breast Cancer | 1 |
| Dana-Farber Cancer Institute - Merrimack Valley | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Dana-Farber Cancer Institute Merrimack Valley | Metastatic Breast Cancer | 1 |
| Dana-Farber Cancer Instiute Merrimack Valley | EGFR Gene Mutation, Lung Cancer | 1 |
Recruiting trials in Methuen grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Massachusetts are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Massachusetts trials follow additional state privacy requirements enforced under 201 CMR 17.00 and oversight from the Massachusetts Department of Public Health.
Hipa.ai aggregates every recruiting study in Methuen from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 23 recruiting clinical trials in Methuen, Massachusetts listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Methuen compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Methuen include Breast Cancer (2), Major Depressive Disorder (2), Stage IIIB Lung Cancer AJCC v8 (2), Advanced Esophageal Adenocarcinoma (1), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Methuen on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Methuen include Dana Farber-Merrimack Valley, ActivMed Practices and Research, Activmed Practices & Research, Llc - Methuen, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Methuen are Cancer & tumors (15), Mental health & behavior (1), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.